SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Humanized Mouse and Rat Model (Genetic, Cell-Based (CD34, PBMC, BLT)) Market - Global Forecast to 2022 - ResearchAndMarkets.com
[April 16, 2018]

Humanized Mouse and Rat Model (Genetic, Cell-Based (CD34, PBMC, BLT)) Market - Global Forecast to 2022 - ResearchAndMarkets.com


The "Humanized Mouse and Rat Model Market by Type, Application & End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The humanized mouse models market is projected to reach USD 128.9 million by 2022 from USD 80.3 million in 2017, at a CAGR of 9.9% during the forecast period. The humanized rat models market is expected to reach USD 8.9 million by 2022 from USD 5.9 million in 2017, at a CAGR of 8.4% during the forecast period.

The major influencing factors driving the growth of this market are increasing number of research activities involving humanized models, growing demand for personalized medicine, increasing number of R&D activities in pharmaceutical and biotechnology companies, and continuous support in the form of investments and grants from the government and private sectors.

On the basis of type, the humanized mouse models are segmented into genetic and cell-based humanized mouse models. The cell-based humanized mouse models segment is expected to grow at the highest CAGR during the study period (2017-2022). The high growth of this segment can be attributed to the growing applications of cell-based humanized mouse models.

Furthermore, the cell-based humanized mouse models ar categorized into CD34, PBMC, and BLT humanized mouse models. The CD34 humanized mouse models segment is estimated to account for the largest share and register the highest growth rate during the forecast period.



The major factors contributing the large share and high growth rate of this segment include usage of CD34 mouse models in in-vivo platforms for analyzing the safety and effectiveness of potential new drugs that can modulate the immune system. Thus, the growing application areas of CD34 models are likely to spur the market during the forecast period.

Humanized mouse models market is categorized into three end-user segments, namely, pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions. The contract research organizations (CROs) segment of the market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the increasing number of pharmaceutical companies outsourcing their preclinical studies to contract research organizations (CROs).


Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Clinical Trails & Research Studies Assessment

7 Humanized Mouse and Rat Models Market, By Type

8 Humanized Mouse Models Market, By Application

9 Humanized Mouse Models Market, By End User

10 Humanized Mouse Models Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Axenis
  • Champions Oncology
  • Charles River Laboratories
  • Crown Bioscience (Subsidiary of Jsr Corporation)
  • Genoway
  • Harbour Antibodies (A Subsidiary of Harbour Biomed)
  • Hera Biolabs
  • Horizon Discovery (Sage Labs)
  • Ingenious Targeting Laboratory
  • Taconic Biosciences
  • The Jackson Laboratory
  • Trans Genic
  • Vitalstar Biotechnology

For more information about this report visit https://www.researchandmarkets.com/research/s6pnnj/humanized_mouse?w=4


[ Back To TMCnet.com's Homepage ]







Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy